These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 31657132)
1. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway. Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132 [TBL] [Abstract][Full Text] [Related]
2. Suppression of long non-coding RNA TNRC6C-AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway. Yang LX; Wu J; Guo ML; Zhang Y; Ma SG Cell Prolif; 2019 May; 52(3):e12564. PubMed ID: 30938030 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy. Fan L; Li H; Wang W Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850 [TBL] [Abstract][Full Text] [Related]
4. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p. Hou S; Lin Q; Guan F; Lin C J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424 [TBL] [Abstract][Full Text] [Related]
5. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway. Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116 [TBL] [Abstract][Full Text] [Related]
6. LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression. Yao W; Hou J; Liu G; Wu F; Yan Q; Guo L; Wang C Cancer Biomark; 2023; 36(1):1-16. PubMed ID: 35912730 [TBL] [Abstract][Full Text] [Related]
7. Silencing long non-coding RNA DLX6-AS1 or restoring microRNA-193b-3p enhances thyroid carcinoma cell autophagy and apoptosis via depressing HOXA1. Feng L; Wang R; Wang Y; Shen X; Shi Q; Lian M; Ma H; Fang J J Cell Mol Med; 2021 Oct; 25(19):9319-9330. PubMed ID: 34514705 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway. Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203 [TBL] [Abstract][Full Text] [Related]
9. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells. Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA_0057209 Acts as ceRNA to Inhibit Thyroid Cancer Progression by Promoting the STK4-Mediated Hippo Pathway Peng X; Zhu Y; Lin S; Yu W; Zhang C; Tan L; Long M; Luo D; Ji C Oxid Med Cell Longev; 2022; 2022():9974639. PubMed ID: 35308166 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis. Guo F; Fu Q; Wang Y; Sui G J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation. Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC00607 silencing exerts antioncogenic effects on thyroid cancer through the CASP9 Promoter methylation. Li L; Gao Z; Zhao L; Ren P; Shen H J Cell Mol Med; 2021 Aug; 25(16):7608-7620. PubMed ID: 34232553 [TBL] [Abstract][Full Text] [Related]
14. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1. Chen H; Hou G; Yang J; Chen W; Guo L; Mao Q; Ge J; Zhang X J Cell Mol Med; 2020 Jun; 24(11):6070-6082. PubMed ID: 32329150 [TBL] [Abstract][Full Text] [Related]
15. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
16. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221 [TBL] [Abstract][Full Text] [Related]
17. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway. Song W; Zhang J; Xia Q; Sun M Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201 [No Abstract] [Full Text] [Related]
18. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2. Zhao Y; Zhao L; Li J; Zhong L J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261 [TBL] [Abstract][Full Text] [Related]
19. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1. Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950 [TBL] [Abstract][Full Text] [Related]
20. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]